Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids
- 1 January 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 18 (14) , 4227-4236
- https://doi.org/10.1093/nar/18.14.4227
Abstract
We have developed a strategy for the detection, localization and sequence determination of point mutations in the mRNA coding for the .alpha.1(I) and .alpha.2(I) chains of type I collagen. Point mutations are detected by RNase A cleavage of mismatches in RNA/RNA hybrids. The mRNAs coding for the fibrillar collagens, present special problems for hybrid analysis because of their large size and their GC-rich and repetitive sequences. We have generated a series of overlapping antisense riboprobes covering the entire pro.alpha.1(I) and pro.alpha.2(I) mRNAs. Uniformly labelled normal antisense riboprobes are hybridized with the total fibroblast RNA of patients with possible mutations in type I collagen. Mismatches in the resulting RNA/RNA hybrids are cleaved with RNase A and the labelled riboprobe cleavage products are examined electrophoretically. The sensitivity and specificity of the system were demonstrated by the detection and localization of a known point mutation in the codon for .alpha.1(I) glycine 988 (1). DNA for sequencing the mutations localized hybrid analysis may be obtained by either (1) generation of a fibroblast cDNA library and isolation of both alleles by plaque screening, or (2) a more rapid method using first strand cDNA synthesis from poly (A+)-mRNA, followed by PCR amplification of the mutation-containing region of the DNA/RNA hybrid. This strategy for detection and isolation has wide application not only for mutations causing connective tissue disorders, but also for mutations in other large and repetitive genes. We have used this strategy for the detection and sequencing of a point mutation in .alpha.2(I) mRNA associated with a case of lethal osteogenesis imperfecta. The G .fwdarw. A point mutation in the codon for .alpha.2(I) glycine residue 805 results in the substitution of an aspartic acid at this position and is consistent with the proband''s collagen protein data.This publication has 26 references indexed in Scilit:
- A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.Journal of Clinical Investigation, 1989
- Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA.Journal of Biological Chemistry, 1988
- Organization of the human pro-alpha 2(I) collagen gene.Journal of Biological Chemistry, 1987
- A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.Journal of Biological Chemistry, 1987
- Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.Journal of Biological Chemistry, 1987
- Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.Proceedings of the National Academy of Sciences, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Detection of Single Base Substitutions by Ribonuclease Cleavage at Mismatches in RNA:DNA DuplexesScience, 1985
- Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.Journal of Biological Chemistry, 1985
- Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.Proceedings of the National Academy of Sciences, 1981